 Record date **PHI** Oncology COMPLETION NOTE Patient **PHI** **PHI** # **PHI** RADIATION ONCOLOGIST **PHI** **PHI** **PHI** , MD DATES OF RADIATION **PHIDate** **PHIDate** ( 58 elapsed days ) DIAGNOSIS Prostate adenocarcinoma T2B Nx , Gleason 4+3 = 7 , PSA 7.1 CONCISE HISTORY Mr. **PHI** is a 63 year old man who was found to have an elevated PSA of 7.1 on screening exam . An abnormality was also noted on DRE at that time . Prostate biopsy was performed , and all 12 cores were positive for disease , including 8 cores with Gleason 7 disease . Prostatic MRI showed no evidence of extracapsular extension . CT of the abdomen and bone scan revealed no evidence of metastatic disease . He was treated with definitive radiation to the prostate and seminal vesicles by **PHI** , with concomitant Zoladex treatment . SPECIAL TECHNICAL **PHI** The patient underwent CT based imaging to define the target volume and the normal tissue structures and 3D treatment planning was performed for treatment with **PHI** . Daily localization of the prostate was done using the BAT ultrasound . SUMMARY OF RADIATION AND TREATMENT ADMINISTERED The treatment site was the prostate gland plus the caudal seminal vesicles followed by a boost to the prostate alone . The patient underwent external beam radiotherapy to the prostate and caudal seminal vesicles to a dose of 45 Gy given as 25 fractions of 1.8 Gy day . He then underwent a boost to the prostate only of 34 . Gy given in 17 fractions of 2 Gy day for a total dose of 79 Gy . CLINICAL COURSE The patient developed mild **PHI** and more frequent bowel movements , for which he took Flomax and Metamucil . Mr. **PHI** has tolerated his androgen deprivation therapy well . FOLLOW UP Mr. **PHI** will follow up with us in 3 months with a PSA in advance . Ulysses **PHI** , MD ( Resident ) **PHI** **PHI** , MD ( Attending ) cc